Diabetes 67(Supplement 1):522 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Although animal models provide strong evidence of causality ( A glaring gap is the scarcity of robust clinical trials designed to simultaneously assess gastroenterological and neuropsychiatric outcomes as co-primaries
Avoid taking the capsule in the evening because phentermine is a stimulant and can cause sleep difficulties
Zheng, H., Gupta, V., Patterson-Fortin, J., Bhattacharya, S., Katlinski, K., Wu, J., et al
Las modificaciones dietticas estratgicas pueden mitigar significativamente los problemas intestinales asociados con los medicamentos GLP-1, mejorando tanto la tolerabilidad como la efectividad del tratamiento
Due to persistent vomiting, he was unable to eat, so consequently, he did not administer prandial insulin, only occasionally using small doses of rapid-acting insulin once or twice daily in response to elevated blood glucose levels